{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:00:49Z","timestamp":1790506849273,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.02.060","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T18:15:41Z","timestamp":1489688141000},"page":"2007-2014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical development strategy for a candidate group A streptococcal vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Florian","family":"Sch\u00f6del","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet T.","family":"Wittes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.060_b0005","first-page":"1","article-title":"Group A streptococcal diseases and their global burden","volume":"368","author":"Ralph","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.02.060_b0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MOP.0000000000000164","article-title":"Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?","volume":"27","author":"de Dassel","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2017.02.060_b0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1440-1754.2010.01841.x","article-title":"Rheumatic fever in indigenous Australian children","volume":"46","author":"Parnaby","year":"2010","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2017.02.060_b0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1440-1754.2012.02447.x","article-title":"Incidence of acute rheumatic fever in New Zealand children and youth","volume":"48","author":"Milne","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2017.02.060_b0030","series-title":"Interim evaluation of the sore throat component of the rheumatic fever prevention programme \u2013 quantitative findings","author":"Jack","year":"2015"},{"key":"10.1016\/j.vaccine.2017.02.060_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QCO.0b013e3283511d27","article-title":"Streptococcal skin infection and rheumatic heart disease","volume":"25","author":"Parks","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/506938","article-title":"Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic","volume":"43","author":"McDonald","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0045","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1371\/journal.pntd.0000467","article-title":"High burden of impetigo and scabies in a tropical country","volume":"3","author":"Steer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/civ1032","article-title":"The impact of obesity and diabetes on the risk of disease and death due to invasive group A Streptococcus infections in adults","volume":"62","author":"Langley","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciw420","article-title":"Invasive group A streptococcal infections in indigenous New Zealanders with type 2 diabetes","volume":"63","author":"Williamson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0060","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.060_b0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0070","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/JCM.02129-15","article-title":"M-protein analysis of streptococcus pyogenes isolates associated with acute rheumatic fever in New Zealand","volume":"53","author":"Williamson","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.02.060_b0075","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1086\/519384","article-title":"Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States","volume":"45","author":"Erdem","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0080","series-title":"Streptococcus pyogenes: basic biology to clinical manifestations","article-title":"Current approaches to group A streptococcal vaccine development","author":"Dale","year":"2016"},{"key":"10.1016\/j.vaccine.2017.02.060_b0085","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.vaccine.2014.05.017","article-title":"Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop","volume":"32","author":"Moreland","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.060_b0090","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.060_b0095","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1093\/cid\/ciu490","article-title":"The emm-cluster typing system for group A Streptococcus identifies epidemiologic similarities across the Pacific region","volume":"59","author":"Baroux","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/14760584.2016.1116946","article-title":"Development of group A streptococcal vaccines: an unmet global health need","volume":"15","author":"Sheel","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.02.060_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-0484","article-title":"Burden and economic cost of group A streptococcal pharyngitis","volume":"121","author":"Pfoh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.02.060_b0110","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrcardio.2012.157","article-title":"Screening for rheumatic heart disease: current approaches and controversies","volume":"10","author":"Roberts","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.vaccine.2017.02.060_b0120","doi-asserted-by":"crossref","first-page":"167089","DOI":"10.1155\/2015\/167089","article-title":"Correlates of protection for M protein-based vaccines against group A Streptococcus","volume":"2015","author":"Tsoi","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2017.02.060_b0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CVI.13.4.459-466.2006","article-title":"Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae","volume":"13","author":"Martinez","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.02.060_b0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/jpids\/piu030","article-title":"The group A streptococcal carrier state reviewed: still an enigma","volume":"3","author":"DeMuri","year":"2014","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2017.02.060_b0135","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1542\/peds.2006-3368","article-title":"Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia","volume":"120","author":"Danchin","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.02.060_b0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/INF.0b013e318194b2af","article-title":"Prospective surveillance of streptococcal sore throat in a tropical country","volume":"28","author":"Steer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.02.060_b0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0971-5916.93437","article-title":"Streptococcus pyogenes pharyngitis & impetigo in a rural area of Panchkula district in Haryana, India","volume":"135","author":"Kumar","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2017.02.060_b0150","doi-asserted-by":"crossref","first-page":"e0136789","DOI":"10.1371\/journal.pone.0136789","article-title":"The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma","volume":"10","author":"Bowen","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.02.060_b0155","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"Romani","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.060_b0160","unstructured":"World Health Organization. Regional consultation to standardize EPI schedule in the eastern mediterranean region of the World Health Organization; October 2006."},{"key":"10.1016\/j.vaccine.2017.02.060_b0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jama.1969.03150190037007","article-title":"Rheumatic fever following streptococcal vaccination. Report of three cases","volume":"207","author":"Massell","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.02.060_b0170","series-title":"Rheumatic fever and streptococcal infection: unraveling the mysteries of a dread disease","author":"Massell","year":"1997"},{"key":"10.1016\/j.vaccine.2017.02.060_b0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/QCO.0b013e328332bbfe","article-title":"Group A streptococcal vaccines: facts versus fantasy","volume":"22","author":"Steer","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0180","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2017.02.060_b0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","article-title":"World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease\u2013an evidence-based guideline","volume":"9","author":"Rem\u00e9nyi","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.vaccine.2017.02.060_b0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1542\/peds.2006-3606","article-title":"Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever","volume":"120","author":"Miyake","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.02.060_b0195","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4269\/ajtmh.2011.11-0185","article-title":"Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature","volume":"85","author":"Marshall","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.02.060_b0200","series-title":"Streptococcus pyogenes: basic biology to clinical manifestations","article-title":"Post-streptococcal glomerulonephritis","author":"Rodriguez-Iturbe","year":"2016"},{"key":"10.1016\/j.vaccine.2017.02.060_b0205","first-page":"1","article-title":"Acute post sreptococcal glomerulonephritis in the Northern Territory 1980\u20132000","volume":"8","author":"Evans","year":"2001","journal-title":"NT Dis Control Bull"},{"key":"10.1016\/j.vaccine.2017.02.060_b0210","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ki.2011.478","article-title":"Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life","volume":"81","author":"Hoy","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2017.02.060_b0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/ndt\/gfu241","volume":"31","author":"Hoy","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vaccine.2017.02.060_b0220","series-title":"Streptococcus pyogenes: basic biology to clinical manifestations","article-title":"Epidemiology of Streptococcus pyogenes","author":"Efstratiou","year":"2016"},{"key":"10.1016\/j.vaccine.2017.02.060_b0225","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3201\/eid2202.151358","article-title":"Invasive group A Streptococcus infection among children, rural Kenya","volume":"22","author":"Seale","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.060_b0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3201\/eid15\/2.080558","article-title":"Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005\u20132007","volume":"15","author":"Steer","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2017.02.060_b0235","first-page":"148","article-title":"Invasive group A streptococcal disease in North Queensland (1996\u20132001)","volume":"119","author":"Norton","year":"2004","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2017.02.060_b0240","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/jpc.12659","article-title":"Invasive group A streptococcal infection in the Northern Territory, Australia: case report and review of the literature","volume":"50","author":"Middleton","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2017.02.060_b0245","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/342062","article-title":"Population-based surveillance for postpartum invasive group A streptococcus infections, 1995\u20132000","volume":"35","author":"Chuang","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.02.060_b0250","first-page":"1","article-title":"Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2017.02.060_b0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jpc.12808","article-title":"Historical aspects of rheumatic fever","volume":"51","author":"Steer","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2017.02.060_b0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T23:39:36Z","timestamp":1750117176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17302736"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical development strategy for a candidate group A streptococcal vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}